BackFirst Tracks Biotherapeutics Ordinary Shares When-Issued Overview

First Tracks Biotherapeutics Ordinary Shares When-Issued Current Cash

Track First Tracks Biotherapeutics Ordinary Shares When-Issued's current cash ($160M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$155.63M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Current Cash History

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued vs. peers: Current Cash Comparison

Loading

First Tracks Biotherapeutics Ordinary Shares When-Issued Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Tracks Biotherapeutics Ordinary Shares When-Issued (TRAXV) FAQ

The latest current cash for TRAXV is $160M as of September 2026. Investors often review this figure alongside First Tracks Biotherapeutics Ordinary Shares When-Issued's historical trend and sector peers before judging valuation or financial health.

A current cash figure of $160M for TRAXV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TRAXV's current cash ($160M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack First Tracks Biotherapeutics Ordinary Shares When-Issued's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.